AbbVie, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US00287Y1091
USD
228.71
-1.53 (-0.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
56,334.00
54,318.00
58,054.00
56,197.00
45,804.00
33,266.00
32,753.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
56,334.00
54,318.00
58,054.00
56,197.00
45,804.00
33,266.00
32,753.00
Raw Material Cost
16,831.00
16,650.00
16,445.00
17,144.00
14,118.00
7,606.00
7,557.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2,954.00
2,360.00
2,346.00
2,449.00
2,519.00
1,815.00
1,348.00
Selling and Distribution Expenses
14,563.00
12,548.00
12,520.00
12,324.00
9,883.00
6,708.00
7,329.00
Other Expenses
536.10
467.80
414.10
453.10
365.40
356.20
388.10
Total Expenditure (Excl Depreciation)
39,709.00
36,236.00
35,452.00
36,448.00
30,174.00
19,691.00
20,115.00
Operating Profit (PBDIT) excl Other Income
16625
18082
22602
19749
15630
13575
12638
Other Income
1,232.00
1,056.00
485.00
-226.00
272.00
555.00
-33.00
Operating Profit (PBDIT)
26,243.00
27,836.00
31,554.00
28,044.00
22,373.00
16,487.00
13,870.00
Interest
2,954.00
2,360.00
2,346.00
2,449.00
2,519.00
1,815.00
1,348.00
Exceptional Items
-11,187.00
-10,528.00
-7,264.00
-4,085.00
-9,985.00
-4,229.00
-5,560.00
Gross Profit (PBDT)
39,503.00
37,668.00
41,609.00
39,053.00
31,686.00
25,660.00
25,196.00
Depreciation
8,386.00
8,698.00
8,467.00
8,521.00
6,471.00
2,017.00
1,765.00
Profit Before Tax
3,716.00
6,250.00
13,477.00
12,989.00
3,398.00
8,426.00
5,197.00
Tax
-570.00
1,377.00
1,632.00
1,440.00
-1,224.00
544.00
-490.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4,238.00
4,820.00
11,782.00
11,468.00
4,556.00
7,842.00
5,657.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4,238.00
4,820.00
11,782.00
11,468.00
4,556.00
7,842.00
5,657.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
8.00
10.00
9.00
7.00
6.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4,246.00
4,830.00
11,791.00
11,475.00
4,562.00
7,842.00
5,657.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
3,325.00
10,360.00
17,254.00
15,408.00
13,076.00
-8,172.00
-8,446.00
Earnings per share (EPS)
2.39
2.72
6.63
6.45
2.72
5.28
3.66
Diluted Earnings per share
2.39
2.72
6.63
6.45
2.72
5.28
3.66
Operating Profit Margin (Excl OI)
29.51%
33.29%
38.93%
35.14%
34.12%
41.83%
37.06%
Gross Profit Margin
21.48%
27.52%
37.8%
38.28%
21.55%
31.39%
21.26%
PAT Margin
7.52%
8.87%
20.29%
20.41%
9.95%
23.57%
17.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 3.71% vs -6.44% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -12.09% vs -59.04% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -6.61% vs -13.80% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 25.17% vs 0.60% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of AbbVie, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
56,334.00
88,819.00
-32,485.00
-36.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
56,334.00
88,819.00
-32,485.00
-36.57%
Raw Material Cost
16,831.00
27,862.00
-11,031.00
-39.59%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2,954.00
1,150.00
1,804.00
156.87%
Selling and Distribution Expenses
14,563.00
22,869.00
-8,306.00
-36.32%
Other Expenses
536.10
1,611.50
-1,075.40
-66.73%
Total Expenditure (Excl Depreciation)
39,709.00
67,996.00
-28,287.00
-41.60%
Operating Profit (PBDIT) excl Other Income
16,625.00
20,823.00
-4,198.00
-20.16%
Other Income
1,232.00
3,255.80
-2,023.80
-62.16%
Operating Profit (PBDIT)
26,243.00
31,417.80
-5,174.80
-16.47%
Interest
2,954.00
1,150.00
1,804.00
156.87%
Exceptional Items
-11,187.00
-6,241.80
-4,945.20
-79.23%
Gross Profit (PBDT)
39,503.00
60,957.00
-21,454.00
-35.20%
Depreciation
8,386.00
7,339.00
1,047.00
14.27%
Profit Before Tax
3,716.00
16,687.00
-12,971.00
-77.73%
Tax
-570.00
2,621.00
-3,191.00
-121.75%
Provisions and contingencies
0
0
0.00
Profit After Tax
4,238.00
14,066.00
-9,828.00
-69.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
4,238.00
14,066.00
-9,828.00
-69.87%
Share in Profit of Associates
0
0
0.00
Minority Interest
8.00
0.00
8.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4,246.00
14,066.00
-9,820.00
-69.81%
Equity Capital
0
0
0.00
Face Value
0.01
1.00
0.00
Reserves
3,325.00
71,490.00
-68,165.00
-95.35%
Earnings per share (EPS)
2.39
5.79
-3.40
-58.72%
Diluted Earnings per share
2.39
5.79
-3.40
-58.72%
Operating Profit Margin (Excl OI)
29.51%
23.44%
0.00
6.07%
Gross Profit Margin
21.48%
27.05%
0.00
-5.57%
PAT Margin
7.52%
15.84%
0.00
-8.32%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 5,633.40 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3.71% vs -6.44% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 424.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -12.09% vs -59.04% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,501.10 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -6.61% vs -13.80% in Dec 2023

Annual - Interest
Interest 295.40 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 25.17% vs 0.60% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.51%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023